Jade Biosciences in IgA nephropathy

Kaveri discusses Jade's Jade101 antibody, disease-modifying potential, YTE half-life extension, and market timing after Otsuka approval.

Play episode from 09:22

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!